DC Investments Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$200K Buy
+7,128
New +$190K 0.08% 75
2020
Q4
Sell
-9,307
Closed -$324K 85
2020
Q3
$324K Sell
9,307
-1,917
-17% -$67.2K 0.35% 50
2020
Q2
$348K Sell
11,224
-28,298
-72% -$961K 0.13% 131
2020
Q1
$1.22M Buy
39,522
+25,617
+184% +$873K 0.99% 11
2019
Q4
$517K Sell
13,905
-259
-2% -$9.22K 0.4% 105
2019
Q3
$483K Buy
14,164
+149
+1% +$5.42K 0.28% 141
2019
Q2
$576K Sell
14,015
-1,987
-12% -$78.9K 0.32% 102
2019
Q1
$645K Hold
16,002
0.41% 77
2018
Q4
$663K Sell
16,002
-12,603
-44% -$523K 0.54% 30
2018
Q3
$1.2M Buy
28,605
+13,073
+84% +$503K 0.81% 3
2018
Q2
$535K Sell
15,532
-73,313
-83% -$2.51M 0.34% 154
2018
Q1
$2.99M Buy
88,845
+24,127
+37% +$829K 2.01% 1
2017
Q4
$2.22M Buy
+64,718
New +$2.21M 0.92% 3

Other funds holding PFE

DC Investments Management's PFE Position: Q1 2026 in Review

DC Investments Management opened a new position in Pfizer (PFE) in Q1 2026: 7,128 shares worth $200K. The stake represents 0.08% of the portfolio and ranks #75 among its holdings. This is a return to the name: DC Investments Management previously reported a position in PFE as recently as Q3 2020.

DC Investments Management first reported a position in PFE in Q4 2017 and has held it in 13 quarters since. The position peaked at $2.99M in Q1 2018. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • DC Investments Management held 7,128 shares of Pfizer worth $200K as of Q1 2026.
  • Pfizer was a new DC Investments Management position in Q1 2026.
  • Pfizer made up 0.08% of DC Investments Management's portfolio in Q1 2026, its #75 holding.
  • DC Investments Management first reported a position in Pfizer in Q4 2017 and has held it in 13 quarters since.
  • DC Investments Management's Pfizer position peaked at $2.99M in Q1 2018.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on DC Investments Management's 13F filing for Q1 2026, filed 14 May 2026.